Medical Drugs

Corcept Therapeutics Incorporated (CORT) Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism. Acer Therapeutics Inc. (ACER) Acer Therapeutics Inc., a pharmaceutical company, […]

Biomedical

Biopharmaceuticals

Biotech

Biotechnology

Cancer

Cash

Coronavirus

COVID-19

COVID-19 Pill

COVID-19 Variant

Defensive Stocks

Dividend Stocks

Dividend Yields

Dividends

Drug Development

Drug Platform

Fibonacci Retracement

Free Cash Flow

Fundamental Analysis

Fundamentals

Healthcare

Immunology Biopharmaceutical

Medical

Medicine

Pharmaceuticals

Technical Analysis

US Economy

Vaccine Policy

Vaccines

Valuations

Value Investing

Value Stocks

PFE is up more than 70% over the last year. Could it still offer useful value?

January 11, 2022

As recently as last summer, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As new, even more contagious variants of the virus have emerged, however, it has become […]

Medical Drugs

2 Medical Drug Stocks Set To Move Higher

November 15, 2021

ESSA Pharma Inc. (EPIX) SSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. ESSA Pharma Inc. has a collaboration […]